B
BioNote Inc
KRX:377740
BioNote Inc
KRX:377740
Price:
5 370
KRW
0.19%
Market Closed
Market Cap:
₩548.1B
Relative Value
The Relative Value of one BioNote Inc stock under the Base Case scenario is hidden KRW. Compared to the current market price of 5 370 KRW, BioNote Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BioNote Inc Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
BioNote Inc Competitors
BioNote Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
B
|
BioNote Inc
KRX:377740
|
541.9B KRW | 4.7 | 4.6 | 7.2 | 10.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
375.3B USD | 6.1 | 89.3 | 14.8 | 20.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
194.6B USD | 5.2 | 24.8 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
176B USD | 6 | 20.8 | 13 | 16 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.8B USD | 9.7 | 29.3 | 22.1 | 23.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.6B USD | 5.5 | 17.6 | 13.1 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.1B AUD | 3.1 | 34.1 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
36.7B EUR | 10.4 | 33.4 | 36.1 | 36.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
